PDE3B and HBB are key prognostic biomarkers driving cell proliferation and regulating immune microenvironment in breast cancer
PDE3B and HBB drive breast cancer proliferation and immune modulation, making them promising biomarkers and therapeutic targets. Further research should assess their potential in targeted therapies.
Authors
- Jianping Jiang (ORCID: https://orcid.org/0000-0002-1066-6362)
- Bolong Yin
- Xuebo Yan
- Hui Shen (ORCID: https://orcid.org/0000-0003-3408-8154)
- Xiangrong Luo
Institutions
- The Central Hospital of Shaoyang (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1186/s41065-025-00470-z
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00